Ajmani Karin 4
4 · Progyny, Inc. · Filed Feb 21, 2020
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Ajmani Karin
EVP, Chief of Strategic Dev.
Transactions
- Exercise/Conversion
Common Stock
2020-02-19$0.87/sh+447,472$389,301→ 1,085,513 total - Exercise/Conversion
Common Stock
2020-02-19$0.91/sh+43,047$39,173→ 1,128,560 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-19−447,472→ 174,914 totalExercise: $0.87Exp: 2025-09-15→ Common Stock (447,472 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-19−43,047→ 344,377 totalExercise: $0.91Exp: 2027-08-03→ Common Stock (43,047 underlying)
Footnotes (3)
- [F1]This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019.
- [F2]Fully Vested.
- [F3]One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.